AUTHOR=Pupuleku Aldi , Costa-García Marcel , Farré Domènec , Hengel Hartmut , Angulo Ana , Muntasell Aura , López-Botet Miguel 

TITLE=Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System

JOURNAL=Frontiers in Immunology

VOLUME=Volume 8 - 2017

YEAR=2017

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.01317

DOI=10.3389/fimmu.2017.01317

ISSN=1664-3224

ABSTRACT=Human cytomegalovirus (HCMV) infection promotes the differentiation and persistent expansion of a mature NK cell subset which displays high surface levels of the activating CD94/NKG2C NK cell receptor (NKR), together with additional distinctive phenotypic and functional features. The mechanisms underlying the development of adaptive NK cells remain uncertain but some observations support the involvement of a cognate interaction of CD94/NKG2C with ligand(s) displayed by HCMV-infected cells. To approach this issue, the heterodimer and its adaptor (DAP12) were expressed in the human Jurkat leukemia T cell line; signaling was detected by transfection of a reporter plasmid encoding for Luciferase (Luc) under NFAT/AP1-dependent control. Engagement of the receptor by solid-phase bound CD94- or NKG2C-specific mAbs triggered Luc expression. Moreover, reporter activation was detectable upon interaction with HLA-E+ .221-AEH cells, as well as with .221 cells incubated with synthetic peptides which stabilized surface expression of endogenous HLA-E; the response was specifically antagonized by soluble NKG2C- and HLA-E-specific mAbs. By contrast, activation of Jurkat-NKG2C+ was undetectable upon interaction with human foreskin fetal fibroblasts (HFFF) infected with HCMV laboratory strains (i.e. AD169, Towne), regardless of their differential ability to preserve surface HLA-E expression. On the other hand, infection with two clinical isolates or with the endotheliotropic TB40/E strain triggered Jurkat-NKG2C+ activation; yet, this response was not inhibited by blocking mAbs and was independent of CD94/NKG2C expression. The results are discussed in the framework of previous observations supporting the hypothetical existence of specific ligand(s) for CD94/NKG2C in HCMV-infected cells